Decades of research by the world’s most respected cancer scientists and physicians consistently reveals one conclusion:
This fact led Anpac Bio Co-Founders, Dr. Chris Yu and Dr. Herbert Yu, to ask the question that ultimately launched the company:
Achieving that goal became the Anpac Co-Founders’ quest. They began breaking the problem apart—drawing on expertise in cancer research, bio-chemistry, chemistry, nano-technology, surface science, material science, detection, physics, engineering and manufacturing.
Together they founded Anpac Bio-Medical Science Co., Ltd. in 2008, bringing together a multi-national team of medical, biomedical and nanotechnology scientists, and engineering experts. Their unique, cross-disciplinary approach combines medicine, biochemistry, chemistry, materials, fluid mechanics, signal detection and processing, physics, precision machine engineering, and software engineering—to achieve vastly superior early cancer screening and detection technology.
For more information regarding Anpac Bio’s leadership team and expanded operations, please contact: Info@AnpacBio.com